Alexis Trecourt, Naoual Bakrin, Olivier Glehen, Witold Gertych, Laurent Villeneuve, Sylvie Isaac, Nazim Benzerdjeb, Juliette Fontaine, Catherine Genestie, Peggy Dartigues, Agnès Leroux, François Quenet, Frederic Marchal, Cecile Odin, Lakhdar Khellaf, Magali Svrcek, Sixte Thierry, Marilyn Augros, Alhadeedi Omar, Mojgan Devouassoux-Shisheboran, Vahan Kepenekian
BACKGROUND: Ovarian pseudomyxoma peritonei (OPMP) are rare, without well-defined therapeutic guidelines. We aimed to evaluate cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) to treat OPMP. METHODS: Patients from the French National Network for Rare Peritoneal Tumors (RENAPE) database with proven OPMP treated by CRS/HIPEC and with histologically normal appendix and digestive endoscopy were retrospectively included. Clinical and follow-up data were collected...
February 10, 2024: Annals of Surgical Oncology